Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease

European Radiology

Volumn 15, Issue 1, 2005, Pages 148-157

  Norén, Bengt ^a   Lundberg, Peter ^a   Ressner, Marcus ^a   Wirell, Staffan ^a   Almer, Sven ^a   Smedby, Örjan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Absolute concentrations; Diffuse liver disease; Phosphorus MR spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; ORGANOPHOSPHATE;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNE HEPATITIS; BASAL METABOLIC RATE; BIOCHEMISTRY; CALCULATION; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER LEVEL; LIVER METABOLISM; LIVER SLICE; LIVER WEIGHT; MALE; METABOLITE; NONALCOHOLIC FATTY LIVER; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PROCEDURES; SPECTROSCOPY;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER DISEASES; LIVER FUNCTION TESTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORUS ISOTOPES; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED; STATISTICS, NONPARAMETRIC;

EID: 12144256208     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2434-x     Document Type: Article

References (45)

1. Graham RA, Taylor AH, Brown TR (1994) A method for calculating the distribution of pH in tissues and a new source of pH error from the 31P-NMR spectrum. Am J Physiol 266:R638-R645 1:CAS:528:DyaK2cXitl2ntr8%3D
2. Lundberg P, Harmsen E, Ho C, Vogel HJ (1990) Nuclear magnetic resonance studies of cellular metabolism. Anal Biochem 191:193-222 1:CAS:528:DyaK3MXlvVamuw%3D%3D
3. Buchli R, Duc CO, Martin E, Boesiger P (1994) Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I. Cerebrum, cerebellum, cerebral gray and white matter. Magn Reson Med 32:447-452 1:CAS:528:DyaK2cXmslOht70%3D
4. Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW (1989) Alcoholic liver disease: Quantitative image-guided P-31 MR spectroscopy. Radiology 173:393-400 1:STN:280:By%2BD3MfjvVw%3D
5. Rajanayagam V, Lee RR, Ackerman Z, Bradley WG, Ross BD (1992) Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J Magn Reson Imaging 2:183-190 1:STN:280:By2B38zlslY%3D
6. Oberhaensli R, Rajagopalan B, Galloway GJ, Taylor DJ, Radda GK (1990) Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 31:463-467 1:STN:280:By%2BB2cbnvFM%3D
7. Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR (1996) Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9:141-155 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P
8. Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M (1998) Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 16:205-211 10.1016/S0730-725X(97)00246-4
9. Tosner Z, Dezortova M, Tintera J, Hajek M (2001) Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. Magma 13:40-46 10.1016/S1352-8661(01)00122-3
10. Bottomley PA, Foster TB, Darrow RD (1984) Depth-resolved surface-coil spectroscopy (DRESS) for in vivo 1 H, 31 P, and 13 C NMR. J Magn Reson 59:338-342 1:CAS:528:DyaL2MXisl2n
11. van den Boogaart A, Van Hecke P, Van Huffel S, Graveron-Demilly D, van Ormondt D, de Beer R (1996) MRUI: A graphical user interface for accurate routine MRS data analysis. In: Proceedings of the ESMRMB 13th Annual Meeting, Prague 318
12. A Boogaart van den 1997 A MRUI MANUAL V. 96.3. A user's guide to the Magnetic Resonance User Interface Software Package Delft Technical University Delft
13. van der Veen JWC, de Beer R, Luyten PR, van Ormondt D (1988) Accurate quantification of in vivo 31-P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6:92-98 3352510
14. Robitaille P-M, Robitaille PA, Brown GG, Browns GG (1991) An analysis of the pH-dependent chemical shift behaviour of phosphorus-containing metabolites. J Magn Reson 92:73-84 10.1016/0022-2364(91)90248-R
15. Graham RA, Meyer RA, Szwergold BS, Brown TR (1987) Observation of myo-inositol 1,2-(cyclic) phosphate in a Morris hepatoma by 31P NMR. J Biol Chem 262:35-37 1:CAS:528:DyaL2sXjtVOqtw%3D%3D
16. Bates TE, Williams SR, Gadian DG (1989) Phosphodiesters in the liver: the effect of field strength on the 31P signal. Magn Reson Med 12:145-150 1:CAS:528:DyaK3cXhvVCgsQ%3D%3D
17. de Kruijff B, van den Besselaar AMPH, Cullis PR, van den Bosch H, van Deenen LLM (1978) Evidence for isotropic motion of phospholipids in liver microsomal membranes. A 31 P-NMR study. Biochim Biophys Acta 514:1-8 718902
18. Murphy EJ, Rajagopalan B, Brindle KM, Radda GK (1989) Phospholipid bilayer contribution to 31P NMR spectra in vivo. Magn Reson Med 12:282-289 1:CAS:528:DyaK3cXjt1yhtQ%3D%3D
19. Buchli R, Meier D, Martin E, Boesiger P (1994) Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part II. Muscle, liver, kidney. Magn Reson Med 32:453-458 1:CAS:528:DyaK2cXmsFajt7g%3D
20. Hultman E, Nilsson LH, Sahlin K. (1975) Adenine nucleotide content in human liver; normal values and fructose induced deplation. Scand J Clin Lab Invest 35:245-251 1:CAS:528:DyaE2MXltFWlsrc%3D
21. Matson GB, Meyerhoff DJ, Lawry TJ et al (1993) Use of computer simulations for quantitation of 31P ISIS MRS results. NMR Biomed 6:215-224 1:STN:280:ByyA2cbmvVc%3D
22. Ljungberg M, Starck G, Vikhoff-Baaz B, Alpsten M, Ekholm S, Forssell-Aronsson E (2002) The magnitude of signal errors introduced by ISIS in quantitative 31P MRS. Magma 14:30-38 10.1016/S1352-8661(01)00154-5
23. Kuesel AC, Stoyanova R, Aiken NR et al (1996) Quantitation of resonances in biological 31P NMR spectra via principal component analysis: potential and limitations. NMR Biomed 9:93-104 10.1002/(SICI)1099-1492(199605)9:3<93::AID-NBM410>3.3.CO;2-4
24. Menon DK, Sargentoni J, Taylor-Robinson SD et al (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances. Hepatology 21:417-427 10.1016/0270-9139(95)90102-7
25. Zakian KL, D'Angelica M, Matei C et al (2000) A quantitativce assessement of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging. Magn Reson Imaging 18:181-187 10.1016/S0730-725X(99)00119-8
26. Dixon RM, Angus PW, Rajagopalan B, Radda GK (1991) Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br J Cancer 63:953-958 1:STN:280:By6B1MbkvFc%3D
27. Cox IJ, Bell JD, Peden CJ et al (1992) In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed 5:114-120 1:STN:280:By2A2M3pt1M%3D
28. Brinkmann G, Melchert UH (1992) A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease. Magn Reson Imaging 10:949-956 10.1016/0730-725X(92)90449-A
29. Bell JD, Cox IJ, Sargentoni J et al (1993) A 31 P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1225:71-77 10.1016/0925-4439(93)90124-J
30. Yamane Y, Umeda M, O'Uchi T, Mitsushima T, Nakata K, Nagataki S (1994) Phosphorus-31 nuclear magnetic resonance in vivo spectroscopy of human liver during hepatitis A virus infection. Dig Dis Sci 39:33-38 1:STN:280:ByuC3cbis1U%3D
31. Bourdel-Marchasson I, Biran M, Thiaudiere E et al (1996) 31P magnetic resonance spectroscopy of human liver in elderly patients: Changes according to nutritional status and inflammatory state. Metabolism 45:1059-1061 1:CAS:528:DyaK28Xls1Wmurs%3D
32. Cox IJ (1996) Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol 65:45-81 10.1016/S0079-6107(96)00006-5
33. Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P (1999) Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy. NMR Biomed 12:535-544 10.1002/(SICI)1099-1492(199912)12:8<535::AID-NBM601>3.0.CO;2-1
34. Mann DV, Lam WW, Magnus Hjelm N et al (2002) Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: A 31-phosphorus magnetic resonance spectroscopy study. Gut 50:118-122 10.1136/gut.50.1.118
35. Angus PW, Dixon RM, Rajagopalan B et al (1990) A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. Clin Sci (Colch) 78:33-38 1:STN:280:By%2BC38rkvVI%3D
36. Munakata T, Griffiths RD, Martin PA, Jenkins SA, Shields R, Edwards RH (1993) An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 6:168-172 1:STN:280:ByyB2s%2FpsVU%3D
37. Taylor-Robinson SD, Thomas EL, Sargentoni J, Marcus CD, Davidson BR, Bell JD (1995) Cirrhosis of the human liver: An in vitro 31 P nuclear magnetic resonance study. Biochim Biophys Acta 1272:113-118 10.1016/0925-4439(95)00074-E
38. van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WP (1995) standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 21:443-449 10.1016/0270-9139(95)90106-X
39. Menon DK, Harris M, Sargentoni J, Taylor-Robinson SD, Cox IJ, Morgan MY (1995) In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology 108:776-788 1:STN:280:ByqC1c%2FmtVM%3D
40. Taylor-Robinson SD, Sargentoni J, Bell JD et al (1997) In vivo and in vitro hepatic 31 P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 17:198-209 1:STN:280:ByiH2czmvFw%3D
41. Jalan R, Sargentoni J, Coutts GA et al (1996) Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut 39:141-146 1:STN:280:ByiD3snhslw%3D
42. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD (2003) The relationship of in vivo 31 P MR spectroscopy to histology in chronic hepatitis C. Hepatology 37:788-794 10.1053/jhep.2003.50149
43. Kiyono K, Shibata A, Sone S et al (1998) Relationship of 31 P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Acta Radiol 39:309-314 1:STN:280:DyaK1c3jtlCnsQ%3D%3D
44. Atkinson DE (1968) The energy charge of the adenylate pool as a regulatory parameter - Interaction with feedback modifiers. Biochemistry 7:4030
45. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM (1999) Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. J Am Med Assoc 282:1659-1664 10.1001/jama.282.17.1659